LataMed AI Evaluates Integration of Installment Payments via Cashea to Boost Healthcare Access

LataMed AI Corp. has initiated a strategic evaluation to integrate Cashea's buy-now-pay-later platform, aiming to reduce financial barriers and expand access to private healthcare services in Latin America.

DC Metrowire Staff
Healthcare
LataMed AI Evaluates Integration of Installment Payments via Cashea to Boost Healthcare Access

LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that it has begun an operational, technical, and commercial evaluation to potentially integrate installment-based healthcare payment capabilities through Cashea, a leading buy-now-pay-later financial technology platform in Venezuela. The initiative aims to reduce upfront financial barriers for patients seeking private healthcare services, including consultations, diagnostics, wellness programs, and other eligible offerings within the LataMed AI ecosystem.

Management believes that improving payment accessibility could enhance patient engagement, increase healthcare utilization, drive platform adoption, and broaden access to private healthcare services. By addressing affordability challenges, the Company seeks to strengthen its position as a technology-enabled healthcare marketplace serving patients, providers, and partners throughout Latin America.

The potential integration aligns with LataMed AI’s broader strategy of combining artificial intelligence, telehealth infrastructure, care coordination tools, and digital payment accessibility to create a scalable healthcare marketplace. Dr. Kevin Rodan Levy, Chief Executive Officer, stated: “We believe financial accessibility is a critical component of healthcare delivery. Our objective is to evaluate solutions that may help patients obtain timely medical care while expanding the reach and utility of our healthcare ecosystem.” He added that such initiatives could strengthen patient acquisition, improve engagement, and support long-term platform growth.

The Company has not entered into a definitive commercial agreement as of the date of this release. Completion of any integration remains subject to further commercial discussions, technical implementation requirements, regulatory review, and customary business conditions. LataMed AI intends to provide updates as material developments occur. For additional information, visit https://latamed.ai or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.

This press release contains forward-looking statements regarding the Company’s business strategy, proposed payment integration initiatives, and future operations. These statements are based on current expectations and assumptions and are subject to significant risks and uncertainties, including the Company’s ability to implement its business plan, obtain financing, secure regulatory authorizations, and successfully negotiate payment integration arrangements. Actual results may differ materially. The Company undertakes no obligation to update forward-looking statements except as required by law.

Blockchain Registration

QR Code for Blockchain Registration